Skip to content


Tag: PCR

Bioanalytical Support for Gene Therapy Programs

An Introduction to Gene Therapy: As early as the 1970’s, the term “gene therapy” was used for the treatment of genetic disorders at the DNA…

Read More

How Have Advanced Drug Modalities Impacted Bioanalysis?

...of drug types that are continually evolving and providing room for improvement in bioanalysis.   References: Partner With BioAgilytix BioAgilytix is a leading…

Read More

Strategies To Overcome Bioanalytical Challenges

Strategies to overcome bioanalytical challenges in Cell & Gene Therapies development With advancements in molecular and cellular engineering techniques, the number of cell and gene…

Read More

Cell and Gene Therapies Account for a Large Portion of the Therapeutics Market

Cell and gene therapies have gone through a growth spurt in the last decade. According to data from the Alliance for Regenerative Medicine (ARM), during…

Read More

FDA RACE for Children Act: What You Should Know

Short for Research to Accelerate Cures and Equity, the RACE Act went into effect on August 18, 2020, and significantly increased the number of required…

Read More

CLIA Requirements for Gene and Cell Therapy Programs

It's a common misconception that all aspects of cell & gene therapy research and development are excluded from CLIA oversight. We take a closer look…

Read More

Bioanalytical Testing Under GMP: Assuring Biologic Safety & Efficacy via Impurities Assays

We discuss the need to put phase-appropriate methods in place to identify and quantify both process- and host-cell related impurities throughout the drug development process.

Read More

A History of Gene Therapy: Exploring Lessons Learned In Light of New Approvals

The FDA recently approved the first gene therapy for pediatric patients with SMA, signifying a major step forward for the therapeutic field as a whole.…

Read More